Alembic Pharma Jumps Over 8% On Joint Venture With Orbicular Pharma

Mumbai: Shares of Alembic Pharmaceuticals Ltd (APL) on Thursday surged over 8 per cent after the company entered into a joint venture with Orbicular Pharmaceutical to develop, manufacture and commercialise dermatology products for global markets. The stock climbed 8.14 per cent to Rs 618 on BSE. At NSE, it zoomed 8 per cent to Rs 618.25. APL on Thursday informed BSE it has entered into a joint venture with Orbicular Pharmaceutical T...